Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/31699Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Wilson, MG | - |
| dc.contributor.author | Waddell, K | - |
| dc.contributor.author | Gauvin, François-Pierre | - |
| dc.contributor.author | Mansilla, C | - |
| dc.contributor.author | Moat, KA | - |
| dc.contributor.author | Wang, Q | - |
| dc.contributor.author | Lavis, JN | - |
| dc.date.accessioned | 2025-05-22T14:42:10Z | - |
| dc.date.available | 2025-05-22T14:42:10Z | - |
| dc.date.issued | 2020-04 | - |
| dc.identifier.citation | Wilson, MG, Waddell K, Gauvin FP, Mansilla C, Moat KA, Wang Q, Lavis JN. COVID-19 rapid evidence profile #3: What is the evidence about international and Canadian experiences with asymptomatic screening to identify COVID-19 cases and to prevent transmission? Hamilton: McMaster Health Forum, 29 April 2020. | en_US |
| dc.identifier.uri | http://hdl.handle.net/11375/31699 | - |
| dc.description.abstract | An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian provinces and territories, about international and Canadian experiences with asymptomatic screening to identify COVID-19 cases and to prevent transmission in response to a decision-maker’s request. | en_US |
| dc.description.sponsorship | The McMaster Health Forum is one of the three co-leads of RISE, which is supported by a grant from the Ontario Ministry of Health to the McMaster Health Forum. | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartofseries | REP 3; | - |
| dc.subject | international | en_US |
| dc.subject | Canadian | en_US |
| dc.subject | asymptomatic | en_US |
| dc.subject | screening | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | transmission | en_US |
| dc.title | COVID-19 rapid evidence profile #3: What is the evidence about international and Canadian experiences with asymptomatic screening to identify COVID-19 cases and to prevent transmission? | en_US |
| Appears in Collections: | Rapid evidence profiles | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| covid-19-rep-3_asymptomatic-screening (2).pdf | 296.66 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
